Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Feb;48(1):M40–M45. doi: 10.1136/mp.48.1.m40

Activation by interferon-γ of expression of ICAM-1 and MHC class II antigens in tumour cells from colorectal carcinomas

I Donnellan 1,2, J Cantrill 1,2, I Fraser 1,2, A Morris 1,2
PMCID: PMC407918  PMID: 16695974

Abstract

Aims—To determine whether lack of MHC class II antigen and intercellular adhesion molecule-1 (ICAM-1) expression in some tumours is due to the inability of the tumour cells to respond to the cytokine interferon-γ (IFN-γ), an important activator of these surface molecules.

Methods—Cells from 40 colorectal tumours which did not constitutively express class II MHC antigens or ICAM-1 were kept in short term culture after disaggregation for a few days to two weeks without significant loss of viability. These were treated with IFN-γ. Expression of class II MHC antigens and ICAM-1 was determined using immunohistological techniques.

Results—There was clear induction in vitro of both MHC class II antigens and ICAM-1 in cells from eight of the tumours, with between 50 and 80% of the tumour cells in the cultures staining positively. The staining was apparent within 24 hours, appeared maximal at about three days, and declined thereafter. There were no obvious differences in cell morphology or viability between the cultures which were inducible and those which were not, nor were there obvious differences between the tumours from which they were derived.

Conclusions—Expression of MHC class II antigens and ICAM-1 may be induced by IFN-γ in a small proportion of colorectal tumours which do not constitutively express these antigens, showing that only a minority of tumours are capable of responding to this cytokine.

Keywords: MHC class II antigens

Keywords: ICAM-1

Keywords: interferon-γ

Keywords: colorectal tumours

Full text

PDF
M40

Images in this article

M42Image
on p.M42

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen C. A., Hogg N. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res. 1987 Jun 1;47(11):2919–2923. [PubMed] [Google Scholar]
  2. Andersen C. B., Ladefoged S. D., Larsen S. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. APMIS. 1994 Jan;102(1):23–37. [PubMed] [Google Scholar]
  3. Concha A., Esteban F., Cabrera T., Ruiz-Cabello F., Garrido F. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol. 1991 Feb;2(1):47–54. [PubMed] [Google Scholar]
  4. Dustin M. L., Springer T. A. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol. 1988 Jul;107(1):321–331. doi: 10.1083/jcb.107.1.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eisenbach L., Hollander N., Greenfeld L., Yakor H., Segal S., Feldman M. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. Int J Cancer. 1984 Oct 15;34(4):567–573. doi: 10.1002/ijc.2910340421. [DOI] [PubMed] [Google Scholar]
  6. Esteban F., Ruiz-Cabello F., Concha A., Pérez-Ayala M., Sánchez-Rozas J. A., Garrido F. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis. 1990 Jul-Aug;8(4):319–328. doi: 10.1007/BF01810678. [DOI] [PubMed] [Google Scholar]
  7. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P. L. Natural history of HLA expression during tumour development. Immunol Today. 1993 Oct;14(10):491–499. doi: 10.1016/0167-5699(93)90264-L. [DOI] [PubMed] [Google Scholar]
  8. Glimcher L. H., Kara C. J. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol. 1992;10:13–49. doi: 10.1146/annurev.iy.10.040192.000305. [DOI] [PubMed] [Google Scholar]
  9. Gregory C. D., Murray R. J., Edwards C. F., Rickinson A. B. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med. 1988 Jun 1;167(6):1811–1824. doi: 10.1084/jem.167.6.1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hilton D. A., West K. P. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer. 1990 Sep 15;66(6):1154–1157. doi: 10.1002/1097-0142(19900915)66:6<1154::aid-cncr2820660613>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Hämmerling G. J., Klar D., Pülm W., Momburg F., Moldenhauer G. The influence of major histocompatibility complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta. 1987 Nov 25;907(3):245–259. doi: 10.1016/0304-419x(87)90008-4. [DOI] [PubMed] [Google Scholar]
  12. Kaiserlian D., Rigal D., Abello J., Revillard J. P. Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol. 1991 Oct;21(10):2415–2421. doi: 10.1002/eji.1830211018. [DOI] [PubMed] [Google Scholar]
  13. Kaklamanis L., Gatter K. C., Hill A. B., Mortensen N., Harris A. L., Krausa P., McMichael A., Bodmer J. G., Bodmer W. F. Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. Int J Cancer. 1992 May 28;51(3):379–385. doi: 10.1002/ijc.2910510308. [DOI] [PubMed] [Google Scholar]
  14. Marlin S. D., Springer T. A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 1987 Dec 4;51(5):813–819. doi: 10.1016/0092-8674(87)90104-8. [DOI] [PubMed] [Google Scholar]
  15. McDougall C. J., Ngoi S. S., Goldman I. S., Godwin T., Felix J., DeCosse J. J., Rigas B. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res. 1990 Dec 15;50(24):8023–8027. [PubMed] [Google Scholar]
  16. Möller P., Momburg F., Koretz K., Moldenhauer G., Herfarth C., Otto H. F., Hämmerling G. J., Schlag P. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res. 1991 Jan 15;51(2):729–736. [PubMed] [Google Scholar]
  17. Ransom J. H., Pelle B. A., Hubers H., Keynton L. M., Hanna M. G., Jr, Pomato N. Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cell/bacillus Calmette-Guérin vaccine. Int J Cancer. 1993 Jul 9;54(5):734–740. doi: 10.1002/ijc.2910540505. [DOI] [PubMed] [Google Scholar]
  18. Rothlein R., Czajkowski M., O'Neill M. M., Marlin S. D., Mainolfi E., Merluzzi V. J. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol. 1988 Sep 1;141(5):1665–1669. [PubMed] [Google Scholar]
  19. Rothlein R., Dustin M. L., Marlin S. D., Springer T. A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986 Aug 15;137(4):1270–1274. [PubMed] [Google Scholar]
  20. Schendel D. J., Gansbacher B., Oberneder R., Kriegmair M., Hofstetter A., Riethmüller G., Segurado O. G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol. 1993 Oct 15;151(8):4209–4220. [PubMed] [Google Scholar]
  21. Slingluff C. L., Jr, Cox A. L., Henderson R. A., Hunt D. F., Engelhard V. H. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol. 1993 Apr 1;150(7):2955–2963. [PubMed] [Google Scholar]
  22. Slingluff C. L., Jr, Cox A. L., Stover J. M., Jr, Moore M. M., Hunt D. F., Engelhard V. H. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res. 1994 May 15;54(10):2731–2737. [PubMed] [Google Scholar]
  23. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  24. Townsend A., Ohlén C., Rogers M., Edwards J., Mukherjee S., Bastin J. Source of unique tumour antigens. Nature. 1994 Oct 20;371(6499):662–662. doi: 10.1038/371662a0. [DOI] [PubMed] [Google Scholar]
  25. Vánky F., Wang P., Patarroyo M., Klein E. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother. 1990;31(1):19–27. doi: 10.1007/BF01742491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wölfel T., Hauer M., Klehmann E., Brichard V., Ackermann B., Knuth A., Boon T., Meyer Zum Büschenfelde K. H. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int J Cancer. 1993 Sep 9;55(2):237–244. doi: 10.1002/ijc.2910550212. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES